MedPath

VISIPAQUE 270

VISIPAQUE 270

Approved
DIN Number

02145766

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

ge healthcare canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02145766
AIG Number0126988001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08AB09 IODIXANOL
Product Specifications
Dosage FormSolution
Route of AdministrationIntra-Arterial ,  Intravenous
AHFS Classification36:68.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IODIXANOLActive
Strength: 550 MG / ML
Monograph: IODIXANOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.